Cellics Therapeutics

Cellics Therapeutics leverages the multifaceted Cellular Nanoparticle (CNP™) technology to develop nano-therapeutics. Cellics’ dynamic nanoplatform, Cellular Nanosponges, harnesses the power of cell membranes to craft specialized nanoparticle-based therapeutics. Cellics is a privately held San Diego-based biopharmaceutical company founded by UC San Diego Professor Liangfang Zhang. We are honest with ourselves and transparent with our actions. We are tireless in applying scientific excellence to seek new solutions for big problems. We are inspired to take action, to be courageous, to break boundaries, for the well-being of patients. Cellics and UCSD have a close collaboration to further develop core platform technologies. Cellics and CARB-X have a strategic partnership of up to $15 Million to develop a novel macrophage nanosponge for treating sepsis.